Erythromycin 250 MG Oral Tablet — RxCUI 598006
RxNorm drug concept · Semantic clinical drug
RxCUI 598006
Semantic clinical drug · SCD
● Current RxNorm concept 30 FDA products
73 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI598006
Official nameErythromycin 250 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped30
Package NDCs mapped73
Reported Medicaid activity (SDUD)6,405 prescriptions · 26 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Erythromycin Ophthalmic: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- It treats minor bacterial infections on the surface of the eye, affecting the conjunctiva and/or cornea. It's also used in newborns to help prevent eye infections from gonorrhea or...
- For an eye infection, you apply a ribbon of ointment about 1 cm long directly to the infected area. Depending on how severe it is, this can be done up to 6 times a day. Follow your...
- No. The ointment should stay in the eye and not be flushed out after you apply it. Your vision may feel a bit different for a moment, but that's not a reason to rinse it away.
- Should I rinse it out after putting it in?
🕸️ Concept Web — How Erythromycin 250 MG Oral Tablet Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Erythromycin 250 MG Oral Tablet
RxCUI 598006 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Erythromycin
4053IN
-
Erythromycin
-
Dose forms 6
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Erythromycin Oral Tablet
372064SCDF -
Erythromycin Oral Product
1164504SCDG -
Erythromycin Pill
1164505SCDG -
Oral Tablet
317541DF -
Oral Product
1151131DFG -
Pill
1151133DFG
-
Erythromycin Oral Tablet
-
Clinical & branded drugs 1
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Erythromycin 250 MG
317364SCDC
-
Erythromycin 250 MG
Showing up to 8 concepts per family — 8 of 8 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Erythromycin 250 MG
SCDC · 317364 -
Erythromycin Oral Tablet
SCDF · 372064 -
Erythromycin Oral Product
SCDG · 1164504 -
Erythromycin Pill
SCDG · 1164505
📦 FDA Products & Package NDCs
30 products · 73 package NDCs
73 package NDCs map to RxCUI 598006 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00093-5571-01 | 100 TABLET, FILM COATED in 1 BOTTLE (0093-5571-01) | Erythromycin | Teva Pharmaceuticals USA, Inc. | 2021-05-04 |
| 00093-5571-56 | 30 TABLET, FILM COATED in 1 BOTTLE (0093-5571-56) | Erythromycin | Teva Pharmaceuticals USA, Inc. | 2021-05-04 |
| 00093-5572-01 | 100 TABLET, FILM COATED in 1 BOTTLE (0093-5572-01) | Erythromycin | Teva Pharmaceuticals USA, Inc. | 2021-05-04 |
| 00093-5572-56 | 30 TABLET, FILM COATED in 1 BOTTLE (0093-5572-56) | Erythromycin | Teva Pharmaceuticals USA, Inc. | 2021-05-04 |
| 13668-0606-01 | 100 TABLET, COATED in 1 BOTTLE (13668-606-01) | Erythromycin | Torrent Pharmaceuticals Limited | 2020-07-06 |
| 13668-0606-05 | 500 TABLET, COATED in 1 BOTTLE (13668-606-05) | Erythromycin | Torrent Pharmaceuticals Limited | 2020-07-07 |
| 13668-0606-30 | 30 TABLET, COATED in 1 BOTTLE (13668-606-30) | Erythromycin | Torrent Pharmaceuticals Limited | 2022-04-12 |
| 13668-0607-01 | 100 TABLET, COATED in 1 BOTTLE (13668-607-01) | Erythromycin | Torrent Pharmaceuticals Limited | 2020-07-06 |
| 13668-0607-05 | 500 TABLET, COATED in 1 BOTTLE (13668-607-05) | Erythromycin | Torrent Pharmaceuticals Limited | 2020-07-07 |
| 13668-0607-30 | 30 TABLET, COATED in 1 BOTTLE (13668-607-30) | Erythromycin | Torrent Pharmaceuticals Limited | 2022-04-12 |
| 24338-0102-03 | 30 TABLET, FILM COATED in 1 BOTTLE (24338-102-03) | Erythromycin | Arbor Pharmaceuticals, Inc. | 2017-11-20 |
| 24338-0102-13 | 100 TABLET, FILM COATED in 1 BOTTLE (24338-102-13) | Erythromycin | Arbor Pharmaceuticals, Inc. | 2011-09-06 |
| 24338-0104-03 | 30 TABLET, FILM COATED in 1 BOTTLE (24338-104-03) | Erythromycin | Arbor Pharmaceuticals, Inc. | 2017-11-20 |
| 24338-0104-13 | 100 TABLET, FILM COATED in 1 BOTTLE (24338-104-13) | Erythromycin | Arbor Pharmaceuticals, Inc. | 2011-09-06 |
| 46708-0397-30 | 30 TABLET, FILM COATED in 1 BOTTLE (46708-397-30) | Erythromycin | Alembic Pharmaceuticals Limited | 2023-08-28 |
| 46708-0397-31 | 100 TABLET, FILM COATED in 1 BOTTLE (46708-397-31) | Erythromycin | Alembic Pharmaceuticals Limited | 2023-08-28 |
| 46708-0397-91 | 1000 TABLET, FILM COATED in 1 BOTTLE (46708-397-91) | Erythromycin | Alembic Pharmaceuticals Limited | 2023-08-28 |
| 46708-0398-30 | 30 TABLET, FILM COATED in 1 BOTTLE (46708-398-30) | Erythromycin | Alembic Pharmaceuticals Limited | 2023-08-28 |
| 46708-0398-31 | 100 TABLET, FILM COATED in 1 BOTTLE (46708-398-31) | Erythromycin | Alembic Pharmaceuticals Limited | 2023-08-28 |
| 46708-0398-91 | 1000 TABLET, FILM COATED in 1 BOTTLE (46708-398-91) | Erythromycin | Alembic Pharmaceuticals Limited | 2023-08-28 |
| 50090-5918-05 | 3 TABLET, FILM COATED in 1 BOTTLE (50090-5918-5) | Erythromycin | A-S Medication Solutions | 2022-02-14 |
| 50090-5918-06 | 90 TABLET, FILM COATED in 1 BOTTLE (50090-5918-6) | Erythromycin | A-S Medication Solutions | 2022-06-09 |
| 51407-0855-30 | 30 TABLET, COATED in 1 BOTTLE (51407-855-30) | Erythromycin | Golden State Medical Supply, Inc. | 2023-12-07 |
| 51407-0856-30 | 30 TABLET, COATED in 1 BOTTLE (51407-856-30) | Erythromycin | Golden State Medical Supply, Inc. | 2023-12-07 |
| 52536-0103-03 | 30 TABLET, FILM COATED in 1 BOTTLE (52536-103-03) | Erythromycin | Wilshire Pharmaceuticals | 2018-03-15 |
| 52536-0103-13 | 100 TABLET, FILM COATED in 1 BOTTLE (52536-103-13) | Erythromycin | Wilshire Pharmaceuticals | 2018-03-15 |
| 52536-0105-03 | 30 TABLET, FILM COATED in 1 BOTTLE (52536-105-03) | Erythromycin | Wilshire Pharmaceuticals | 2018-03-15 |
| 52536-0105-13 | 100 TABLET, FILM COATED in 1 BOTTLE (52536-105-13) | Erythromycin | Wilshire Pharmaceuticals | 2018-03-15 |
| 55289-0075-03 | 3 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (55289-075-03) | Erythromycin | PD-Rx Pharmaceuticals, Inc. | 2013-12-18 |
| 55289-0075-40 | 40 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (55289-075-40) | Erythromycin | PD-Rx Pharmaceuticals, Inc. | 2013-12-18 |
| 55289-0075-56 | 56 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (55289-075-56) | Erythromycin | PD-Rx Pharmaceuticals, Inc. | 2013-12-18 |
| 62332-0397-30 | 30 TABLET, FILM COATED in 1 BOTTLE (62332-397-30) | Erythromycin | Alembic Pharmaceuticals Inc. | 2023-08-28 |
| 62332-0397-31 | 100 TABLET, FILM COATED in 1 BOTTLE (62332-397-31) | Erythromycin | Alembic Pharmaceuticals Inc. | 2023-08-28 |
| 62332-0397-91 | 1000 TABLET, FILM COATED in 1 BOTTLE (62332-397-91) | Erythromycin | Alembic Pharmaceuticals Inc. | 2023-08-28 |
| 62332-0398-30 | 30 TABLET, FILM COATED in 1 BOTTLE (62332-398-30) | Erythromycin | Alembic Pharmaceuticals Inc. | 2023-08-28 |
| 62332-0398-31 | 100 TABLET, FILM COATED in 1 BOTTLE (62332-398-31) | Erythromycin | Alembic Pharmaceuticals Inc. | 2023-08-28 |
| 62332-0398-91 | 1000 TABLET, FILM COATED in 1 BOTTLE (62332-398-91) | Erythromycin | Alembic Pharmaceuticals Inc. | 2023-08-28 |
| 67877-0762-01 | 100 TABLET, FILM COATED in 1 BOTTLE (67877-762-01) | ERYTHROMYCIN | Ascend Laboratories, LLC | 2022-07-14 |
| 67877-0762-05 | 500 TABLET, FILM COATED in 1 BOTTLE (67877-762-05) | ERYTHROMYCIN | Ascend Laboratories, LLC | 2022-07-14 |
| 67877-0762-30 | 30 TABLET, FILM COATED in 1 BOTTLE (67877-762-30) | ERYTHROMYCIN | Ascend Laboratories, LLC | 2022-07-14 |
| 67877-0762-33 | 1 BLISTER PACK in 1 CARTON (67877-762-33) / 10 TABLET, FILM... | ERYTHROMYCIN | Ascend Laboratories, LLC | 2022-07-14 |
| 67877-0763-01 | 100 TABLET, FILM COATED in 1 BOTTLE (67877-763-01) | ERYTHROMYCIN | Ascend Laboratories, LLC | 2022-07-14 |
| 67877-0763-05 | 500 TABLET, FILM COATED in 1 BOTTLE (67877-763-05) | ERYTHROMYCIN | Ascend Laboratories, LLC | 2022-07-14 |
| 67877-0763-30 | 30 TABLET, FILM COATED in 1 BOTTLE (67877-763-30) | ERYTHROMYCIN | Ascend Laboratories, LLC | 2022-07-14 |
| 67877-0763-33 | 1 BLISTER PACK in 1 CARTON (67877-763-33) / 10 TABLET, FILM... | ERYTHROMYCIN | Ascend Laboratories, LLC | 2022-07-14 |
| 70710-1047-01 | 100 TABLET, FILM COATED in 1 BOTTLE (70710-1047-1) | Erythromycin | Zydus Pharmaceuticals USA Inc. | 2023-06-30 |
| 70710-1047-03 | 30 TABLET, FILM COATED in 1 BOTTLE (70710-1047-3) | Erythromycin | Zydus Pharmaceuticals USA Inc. | 2023-06-30 |
| 70710-1047-05 | 500 TABLET, FILM COATED in 1 BOTTLE (70710-1047-5) | Erythromycin | Zydus Pharmaceuticals USA Inc. | 2023-06-30 |
| 70710-1048-01 | 100 TABLET, FILM COATED in 1 BOTTLE (70710-1048-1) | Erythromycin | Zydus Pharmaceuticals USA Inc. | 2023-06-30 |
| 70710-1048-03 | 30 TABLET, FILM COATED in 1 BOTTLE (70710-1048-3) | Erythromycin | Zydus Pharmaceuticals USA Inc. | 2023-06-30 |
Observed labelers:
Ascend Laboratories, LLC (8) ·
Alembic Pharmaceuticals Inc. (6) ·
Alembic Pharmaceuticals Limited (6) ·
Torrent Pharmaceuticals Limited (6) ·
Zydus Lifesciences Limited (6) ·
Zydus Pharmaceuticals USA Inc. (6)
· +10 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.